Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam Chen, Mitchel S. Berger, Minhee Won et al.|Nature Medicine|2023Cited by 104
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancerDavid B. Page, Sylvia Adams, Harry D. Bear et al.|npj Breast Cancer|2019Cited by 86
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast CancerNicholas J. Neill, Charles M. Perou, Shankha Satpathy et al.|Cancer Discovery|2025Cited by 3
Figure S3 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast CancerNicholas J. Neill, Charles M. Perou, Shankha Satpathy et al.|Unknown|2025Cited by 0
Figure S1 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast CancerNicholas J. Neill, Charles M. Perou, Shankha Satpathy et al.|Unknown|2025Cited by 0